JP7614477B2 - 間質性肺炎のタンパク質診断バイオマーカー - Google Patents

間質性肺炎のタンパク質診断バイオマーカー Download PDF

Info

Publication number
JP7614477B2
JP7614477B2 JP2021537245A JP2021537245A JP7614477B2 JP 7614477 B2 JP7614477 B2 JP 7614477B2 JP 2021537245 A JP2021537245 A JP 2021537245A JP 2021537245 A JP2021537245 A JP 2021537245A JP 7614477 B2 JP7614477 B2 JP 7614477B2
Authority
JP
Japan
Prior art keywords
interstitial pneumonia
dad
subject
diffuse alveolar
pla2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021537245A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021024856A1 (https=
Inventor
嘉朗 齋藤
亮介 中村
憲昭 荒川
泰雄 大野
高司 泉
元信 佐藤
剛淑 西矢
正幸 花岡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute of Health Sciences
Original Assignee
National Institute of Health Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Institute of Health Sciences filed Critical National Institute of Health Sciences
Publication of JPWO2021024856A1 publication Critical patent/JPWO2021024856A1/ja
Application granted granted Critical
Publication of JP7614477B2 publication Critical patent/JP7614477B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2021537245A 2019-08-02 2020-07-28 間質性肺炎のタンパク質診断バイオマーカー Active JP7614477B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019142706 2019-08-02
JP2019142706 2019-08-02
PCT/JP2020/028866 WO2021024856A1 (ja) 2019-08-02 2020-07-28 間質性肺炎のタンパク質診断バイオマーカー

Publications (2)

Publication Number Publication Date
JPWO2021024856A1 JPWO2021024856A1 (https=) 2021-02-11
JP7614477B2 true JP7614477B2 (ja) 2025-01-16

Family

ID=74503620

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021537245A Active JP7614477B2 (ja) 2019-08-02 2020-07-28 間質性肺炎のタンパク質診断バイオマーカー

Country Status (2)

Country Link
JP (1) JP7614477B2 (https=)
WO (1) WO2021024856A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114113581B (zh) * 2021-11-09 2023-03-10 广州呼吸健康研究院 一种外泌体上kl-6蛋白含量的检测方法及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015500988A (ja) 2011-12-09 2015-01-08 ミカーティス エヌ．ブイ． 肺障害のバイオマーカーとしてのｌｔｂｐ２
JP2016079170A (ja) 2014-10-10 2016-05-16 国立研究開発法人医薬基盤・健康・栄養研究所 細胞遊走調節に関する疾患の予防・治療剤および肺間質の疾患の疾患活動性判定・予後評価
JP2016519763A (ja) 2013-03-15 2016-07-07 インターミューン， インコーポレイテッド プロテオームｉｐｆマーカー

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015500988A (ja) 2011-12-09 2015-01-08 ミカーティス エヌ．ブイ． 肺障害のバイオマーカーとしてのｌｔｂｐ２
JP2016519763A (ja) 2013-03-15 2016-07-07 インターミューン， インコーポレイテッド プロテオームｉｐｆマーカー
JP2016079170A (ja) 2014-10-10 2016-05-16 国立研究開発法人医薬基盤・健康・栄養研究所 細胞遊走調節に関する疾患の予防・治療剤および肺間質の疾患の疾患活動性判定・予後評価

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NORIKO SAKUMA 外、8名，Serum stratifin measurement is useful for evaluating disease severity and outcomes in patients with acute exacerbation of interstitial lung disease: a retrospective study，BMC Pulm Med，2024年，Vol.24,No.1,364， doi: 10.1186/s12890-024-03184-6.，PMID:39075455

Also Published As

Publication number Publication date
WO2021024856A1 (ja) 2021-02-11
JPWO2021024856A1 (https=) 2021-02-11

Similar Documents

Publication Publication Date Title
US8697370B2 (en) Biomarker for diagnosis, prediction and/or prognosis of sepsis and uses thereof
EP2834638B1 (en) Methods for diagnosis and prognosis of sepsis
US11041864B2 (en) Method for prediction of prognosis of sepsis
CN102782501B (zh) 在无症状患者中基于il-6检测的全身炎性应答综合征和败血症的早期诊断和预测
CN108700596A (zh) 用于心血管疾病和事件的诊断和预后方法
US20120010095A1 (en) Methods for diagnosis and prognosis of pulmonary hypertension
EP2167962A2 (en) Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
CN105556308A (zh) 用于阑尾炎的诊断和预后及腹痛病因的区分的方法和组合物
CN113409945A (zh) 一种可预测脓毒症急性肾损伤的模型
WO2014068018A1 (en) Methods of prognosis and diagnosis of sepsis
Ding et al. Diagnostic utility of combined coagulation and inflammatory biomarkers in sepsis stratification: A retrospective study
CN102395888B (zh) 通过测定降钙素原水平对在原发性非感染性疾病患者中的抗生素治疗进行风险评估
JP2013536408A (ja) ガレクチン−３測定によりモニタリングされるスタチン療法
JP7614477B2 (ja) 間質性肺炎のタンパク質診断バイオマーカー
JP2023537224A (ja) Ｃｏｖｉｄ－１９患者の疾患重症度を予測するためのｇｄｆ－１５
CN103733068A (zh) 术后感染症的诊断方法
CN118638739A (zh) Gsdmd在胸痛相关疾病诊断及疗效评估上的用途
JP7705847B2 (ja) 重症薬疹のタンパク質診断バイオマーカー
CN108283013B (zh) 骨髓纤维症的诊断和预后辅助及治疗效果监测方法及装置
Lv et al. Complement receptor CD35 on single urinary extracellular vesicle as novel biomarker of sepsis-associated acute kidney injury
WO2025176110A1 (zh) Ifp35家族蛋白在诊断脓毒症或其相关疾病中的应用
CN121476613A (zh) Ccl5作为免疫检查点抑制剂治疗肿瘤患者不良反应的预测性生物标志物及其应用
WO2021024009A1 (en) Methods and compositions for providing colon cancer assessment using protein biomarkers

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20211129

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20211129

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230621

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240807

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241002

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20241002

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241127

R150 Certificate of patent or registration of utility model

Ref document number: 7614477

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150